Guneet K Jasuja1,2,3, Alexander de Groot4, Emily K Quinn4, Omid Ameli3, Jaclyn M W Hughto5,6,7, Michael Dunbar8, Madeline Deutsch9, Carl G Streed10,11, Michael K Paasche-Orlow10, Hill L Wolfe1,2, Adam J Rose10. 1. Center for Healthcare Organization and Implementation Research (CHOIR), ENRM VAMC, Bedford. 2. Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA. 3. OptumLabs, Eden Prairie, MN. 4. Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA. 5. Departments of Behavioral and Social Sciences and Epidemiology, Brown School of Public Health. 6. Center for Health Promotion and Health Equity, Brown University, Providence, RI. 7. The Fenway Institute, Fenway Health, Boston, MA. 8. RAND Corporation, Health Care Division, Pittsburgh, PA. 9. UCSF Transgender Care, Department of Family and Community Medicine, University of California, San Francisco, CA. 10. Section of General Internal Medicine, BU School of Medicine, Boston Medical Center. 11. Center for Transgender Medicine and Surgery, Boston Medical Center, Boston, MA.
Abstract
BACKGROUND: Large administrative databases often do not capture gender identity data, limiting researchers' ability to identify transgender people and complicating the study of this population. OBJECTIVE: The objective of this study was to develop methods for identifying transgender people in a large, national dataset for insured adults. RESEARCH DESIGN: This was a retrospective analysis of administrative claims data. After using gender identity disorder (GID) diagnoses codes, the current method for identifying transgender people in administrative data, we used the following 2 strategies to improve the accuracy of identifying transgender people that involved: (1) Endocrine Disorder Not Otherwise Specified (Endo NOS) codes and a transgender-related procedure code; or (2) Receipt of sex hormones not associated with the sex recorded in the patient's chart (sex-discordant hormone therapy) and an Endo NOS code or transgender-related procedure code. SUBJECTS: Seventy-four million adults 18 years and above enrolled at some point in commercial or Medicare Advantage plans from 2006 through 2017. RESULTS: We identified 27,227 unique transgender people overall; 18,785 (69%) were identified using GID codes alone. Using Endo NOS with a transgender-related procedure code, and sex-discordant hormone therapy with either Endo NOS or transgender-related procedure code, we added 4391 (16%) and 4051 (15%) transgender people, respectively. Of the 27,227 transgender people in our cohort, 8694 (32%) were transmasculine, 3959 (15%) were transfeminine, and 14,574 (54%) could not be classified. CONCLUSION: In the absence of gender identity data, additional data elements beyond GID codes improves the identification of transgender people in large, administrative claims databases.
BACKGROUND: Large administrative databases often do not capture gender identity data, limiting researchers' ability to identify transgender people and complicating the study of this population. OBJECTIVE: The objective of this study was to develop methods for identifying transgender people in a large, national dataset for insured adults. RESEARCH DESIGN: This was a retrospective analysis of administrative claims data. After using gender identity disorder (GID) diagnoses codes, the current method for identifying transgender people in administrative data, we used the following 2 strategies to improve the accuracy of identifying transgender people that involved: (1) Endocrine Disorder Not Otherwise Specified (Endo NOS) codes and a transgender-related procedure code; or (2) Receipt of sex hormones not associated with the sex recorded in the patient's chart (sex-discordant hormone therapy) and an Endo NOS code or transgender-related procedure code. SUBJECTS: Seventy-four million adults 18 years and above enrolled at some point in commercial or Medicare Advantage plans from 2006 through 2017. RESULTS: We identified 27,227 unique transgender people overall; 18,785 (69%) were identified using GID codes alone. Using Endo NOS with a transgender-related procedure code, and sex-discordant hormone therapy with either Endo NOS or transgender-related procedure code, we added 4391 (16%) and 4051 (15%) transgender people, respectively. Of the 27,227 transgender people in our cohort, 8694 (32%) were transmasculine, 3959 (15%) were transfeminine, and 14,574 (54%) could not be classified. CONCLUSION: In the absence of gender identity data, additional data elements beyond GID codes improves the identification of transgender people in large, administrative claims databases.
Authors: Douglas Roblin; Joshua Barzilay; Dennis Tolsma; Brandi Robinson; Laura Schild; Lee Cromwell; Hayley Braun; Rebecca Nash; Joseph Gerth; Enid Hunkeler; Virginia P Quinn; Vin Tangpricha; Michael Goodman Journal: Ann Epidemiol Date: 2016-02-04 Impact factor: 3.797
Authors: Chris Grasso; Hilary Goldhammer; Danielle Funk; Dana King; Sari L Reisner; Kenneth H Mayer; Alex S Keuroghlian Journal: Am J Public Health Date: 2019-06-20 Impact factor: 9.308
Authors: Gunter Heylens; Els Elaut; Baudewijntje P C Kreukels; Muirne C S Paap; Susanne Cerwenka; Hertha Richter-Appelt; Peggy T Cohen-Kettenis; Ira R Haraldsen; Griet De Cuypere Journal: Br J Psychiatry Date: 2013-05-09 Impact factor: 9.319
Authors: Ada S Cheung; Olivia Ooi; Shalem Leemaqz; Pauline Cundill; Nicholas Silberstein; Ingrid Bretherton; Emily Thrower; Peter Locke; Mathis Grossmann; Jeffrey D Zajac Journal: Transgend Health Date: 2018-12-26
Authors: Clair A Kronk; Avery R Everhart; Florence Ashley; Hale M Thompson; Theodore E Schall; Teddy G Goetz; Laurel Hiatt; Zackary Derrick; Roz Queen; A Ram; E Mae Guthman; Olivia M Danforth; Elle Lett; Emery Potter; Simón E D Sun; Zack Marshall; Ryan Karnoski Journal: J Am Med Inform Assoc Date: 2022-01-12 Impact factor: 7.942
Authors: E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus Journal: Int J Transgend Health Date: 2022-09-06
Authors: Jaclyn M W Hughto; Landon Hughes; Kim Yee; Jae Downing; Jacqueline Ellison; Ash Alpert; Guneet Jasuja; Theresa I Shireman Journal: LGBT Health Date: 2022-03-15 Impact factor: 5.150
Authors: Landon D Hughes; Wesley M King; Kristi E Gamarel; Arline T Geronimus; Orestis A Panagiotou; Jaclyn M W Hughto Journal: Demography Date: 2022-06-01
Authors: Michael S Dunbar; Jaclyn M W Hughto; Guneet K Jasuja; Emily K Quinn; Madeline Deutsch; Asa Radix; Jamie Feldman; Jennifer Abbott; Joshua D Safer; Julie Thompson; Adam J Rose Journal: LGBT Health Date: 2022-03-30 Impact factor: 5.150
Authors: Carl G Streed; Lauren B Beach; Billy A Caceres; Nadia L Dowshen; Kerrie L Moreau; Monica Mukherjee; Tonia Poteat; Asa Radix; Sari L Reisner; Vineeta Singh Journal: Circulation Date: 2021-07-08 Impact factor: 39.918